Chinook Therapeutics Inc Asset Turnover Ratio (KDNY), as of second quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Chinook Therapeutics Inc   (NASDAQ: KDNY)
 

Chinook Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Chinook Therapeutics Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.01 in the second quarter (Jun 30 2023)

Within sector 246 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2023 compared to the preceding quarter from 4075 to 4144.

Asset Turnover Ratio Definition



KDNY Asset Turnover Ratio (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Asset Change -18.78 % 62.25 % 3.51 % 65.04 % 54.79 %
Y / Y Revenue Change 141.15 % -32.22 % -99 % 62425 % 1129.41 %
Asset Turnover Ratio (TTM) 0.01 0.01 0.01 0.12 0.13
KDNY's Total Ranking # 4144 # 4075 # 3537 # 3442 # 3126
Seq. Asset Change -10.31 % -5.46 % -2.68 % -1.57 % 79.17 %
Seq. Revenue Change -44.86 % 257.03 % -79.53 % 498.33 % -84.5 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 247
Healthcare Sector # 639
Overall Market # 4144

Asset Turnover Ratio Statistics
High Average Low
0.12 0.05 -0.05
(Dec 31 2021)   (Sep 30 2021)







Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2023 Assets at quarter ending Jun 30 2023
Therapeutic Solutions International Inc   0.04 $ 0.133  Millions$ 3.709  Millions
Immutep Limited  0.04 $ 5.200  Millions$ 147.449  Millions
Clearside Biomedical Inc   0.03 $ 1.618  Millions$ 47.717  Millions
Roivant Sciences Ltd   0.03 $ 78.585  Millions$ 2,331.728  Millions
Seer Inc   0.03 $ 15.894  Millions$ 480.531  Millions
Stoke Therapeutics Inc   0.03 $ 8.845  Millions$ 268.102  Millions
Lumos Pharma Inc   0.03 $ 2.227  Millions$ 67.900  Millions
Revolution Medicines Inc   0.03 $ 29.524  Millions$ 946.199  Millions
Bolt Biotherapeutics Inc   0.03 $ 6.782  Millions$ 217.547  Millions
Aclarion Inc   0.03 $ 0.083  Millions$ 2.720  Millions
Xoma Royalty Corporation  0.03 $ 4.032  Millions$ 136.460  Millions
Absci Corp  0.03 $ 8.562  Millions$ 302.589  Millions
Arcutis Biotherapeutics Inc   0.03 $ 11.657  Millions$ 414.584  Millions
Miromatrix Medical inc   0.03 $ 0.959  Millions$ 34.516  Millions
Enzo Biochem Inc  0.03 $ 2.442  Millions$ 88.898  Millions
Anavex Life Sciences Corp   0.03 $ 4.271  Millions$ 155.601  Millions
Cardiff Oncology Inc   0.03 $ 2.863  Millions$ 110.957  Millions
Mirati Therapeutics Inc   0.02 $ 27.222  Millions$ 1,113.634  Millions
One World Products Inc   0.02 $ 0.079  Millions$ 3.254  Millions
Senti Biosciences Holdings Inc   0.02 $ 4.047  Millions$ 168.822  Millions
Volitionrx Limited  0.02 $ 0.519  Millions$ 21.810  Millions
Anaptysbio Inc   0.02 $ 12.935  Millions$ 574.445  Millions
Onemednet Corporation  0.02 $ 1.012  Millions$ 45.344  Millions
Cue Biopharma Inc   0.02 $ 1.788  Millions$ 80.607  Millions
Janux Therapeutics Inc   0.02 $ 7.763  Millions$ 358.555  Millions
Dbv Technologies S a   0.02 $ 5.252  Millions$ 245.005  Millions
Meiragtx Holdings Plc  0.02 $ 6.402  Millions$ 304.513  Millions
Sonnet Biotherapeutics Holdings Inc   0.02 $ 0.173  Millions$ 8.752  Millions
Lucid Diagnostics Inc   0.02 $ 0.793  Millions$ 40.624  Millions
Vivosim Labs Inc   0.02 $ 0.445  Millions$ 24.069  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.